© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
CHIR99021 didn’t leap out of nowhere. The search for small molecules that suppress GSK-3 has kept scientists busy for over a decade. GSK-3 inhibitors matter because this enzyme controls many pathways tied to cell division, neural health, metabolism, and regeneration. Early on, researchers played with a jumble of compounds, each one gritty with unpredictable results—some were too weak, others too sloppy, hitting more than the intended targets. CHIR99021 sharpened the game. It showed remarkable selectivity for GSK-3α and GSK-3β, shifting from broad-gauge hope to focused tool. For folks who spend their lives with petri dishes and cell lines, this meant clearer results, fewer worries about side-interference, and much less head-scratching. Scientists saw stem cell colonies grow without surprise differentiation, shifting protocols from shaky guesswork to something repeatable. That consistency matters: progress in fundamental science often depends on having reliable handles. From embryonic stem cells to disease models, CHIR99021 found its spot at the workbench as researchers began to understand how nudging the GSK-3 pathway shapes cell identity and survival.
Rather than being an exotic curiosity, CHIR99021 looks like a fine white powder—small, stable, and easy to handle. What makes it special isn’t how it looks, but what it does in a dish. It blocks activity from GSK-3 enzymes at nanomolar concentrations. That small number says a lot: lower doses mean fewer surprises downstream, and labs can use less material in their media. The compound dissolves pretty well in DMSO, the solvent of choice, keeping things simple for cell culture setups. Once it enters an experiment, researchers see less cell death, steadier stemness, and more predictable differentiation, especially when coaxing embryonic or induced pluripotent stem cells into specific fates. It’s no accident that stem cell protocols regularly place CHIR99021 front and center. It can tip fate toward self-renewal or help direct neural and cardiac development depending on the mix of other factors. Over the years, consistency and potency have made it a reference point in discussions about quality, control, and optimized outcomes.
Even for someone who’s not a synthetic chemist, it’s striking how cleanly CHIR99021 fits together. Built as a pyrazolo-pyrimidine, its structure links efficiency to selectivity. Chemists put serious hours into producing analogs to tweak potency or dial down side effects, but the original still holds strong. Few modifications surpass its profile for both activity and specificity. This is a bit unusual; most chemical probes attract generations of improvement, but CHIR99021 landed on a sweet spot. It’s stable enough for shipping and storage under standard conditions, and reacts little under ordinary lab environments. The main thing you’ll sense mixing it into stock solutions is a faint dustiness, not volatility or strong odor, adding to its user-friendly reputation.
Any scientist who’s looked for CHIR99021 in research papers knows the confusion caused by alternative names. Some call it a “GSK-3 inhibitor” and leave it there. Others drop its long-winded chemical name or just use catalog numbers. This jumble means double-checking protocols before buying or mixing to avoid confusion between similar-sounding compounds or older variations. Out in the wild, you may spot “CHIR,” “CT99021,” or “6-[[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)thiazol-2-yl]amino]pyrimidin-4-yl]amino]cyclohex-1-ene-1-carbonitrile” in the methods sections of high-impact journals. They all point to the same molecular workhorse.
Handling CHIR99021 skips a lot of the anxiety found with truly hazardous chemicals. Sensible safety measures always apply: gloves, goggles, careful pipetting, no open drinks at the bench. Most protocols dilute it by thousands of times before it touches any cells. Storage is more about keeping it cool and dry, away from the worst moisture swings. Ordinary ventilation covers the minor risk of dust. There’s little worry about acute toxicity just from routine use, though inhalation or ingestion should stay on the “never happens” list. Labs I’ve worked in have seen folks mix it with a sense of calm, rarely requiring adsorbents for spills or special waste disposal—reasonable, given the tiny quantities in use compared to some older, nastier reagents.
The story of CHIR99021 really takes off in stem cell biology. In the classroom, researchers talk about “self-renewal,” but in the lab, it translates to cells that don’t randomly quit or split off into weird fates. This compound keeps stem cells undifferentiated or pushes them down needed growth paths, based on the presence of companion agents. It shows up in protocols for mouse and human embryonic stem cells, induced pluripotent stem cell generation, and organoid growth. Some groups have tested its effect in models of diabetes, neurodegeneration, and cancer, watching for shifts in signaling, proliferation, and survival. Results from these efforts keep feeding new protocols, each building on the last. The upshot: researchers can build better models for diseases, run cleaner drug screens, and ask tougher questions about development or repair, all sped up by the stability this inhibitor brings. With new tissue engineering and regenerative medicine projects launching each year, CHIR99021’s role looks set to expand beyond cell culture—potentially toward harnessing cell fates in engineered tissues or therapeutic interventions down the line.
For all its popularity, scientists haven’t turned a blind eye to the downsides. Any compound that tweaks key signaling pathways needs a careful look for off-target effects and unwanted actions. So far, CHIR99021 appears not to unhinge cell growth or genetic stability at the concentrations common in labs, making it a favorite for long-term stem cell work. That being said, much of the published toxicity research still centers on cell lines instead of whole animals or humans. Rigorous work in model organisms continues, hunting for impacts on organ function or developmental outcomes, especially as GSK-3 touches so many body systems. As with many research tools, there’s a line between use in controlled experiments and real-world applications in humans. Responsible scientists keep digging for surprises, wary of hubris every time a new protocol scales up or shifts toward clinical translation.
CHIR99021 keeps cropping up in research proposals and funding calls, both because it solves old problems and opens new questions. The compound helped regularize protocols that once looked like black magic, letting new labs enter stem cell science faster. It also carved out part of the conversation on chemical biology approaches to cell fate. Teams now engineer protocols to combine GSK-3 inhibitors like CHIR99021 with modulators of other cascades, pulling cells down specific differentiation paths with much greater control. Academics and industry groups alike see its value, especially as organoids and patient-derived tissues step into drug screening workflows. There’s also growing curiosity about replacing or refining CHIR99021’s structure for even narrower selectivity or reduced concerns about chronic exposure in eventual therapeutic settings. The more that biologists and chemists cross-pollinate their ideas, the better the chances that the next generation of tools will move science along even faster.
Looking out over the next several years, I see CHIR99021 as both a testament to past problem-solving and a challenge for tomorrow’s investigators. Science doesn’t stand still; every reliable tool brings its own set of questions. People now want compounds with the same ease, potency, and safety but suited for real-life interventions, beyond the confines of culture flasks and incubators. There’s a hunger for new analogs or combinations designed for specific tissue repair or disease reversal, not just cell maintenance. As regenerative medicine matures and stem-cell-based approaches leave the experimental stage, lessons from CHIR99021 will shape the expectations for anything that enters the arena. I’ve watched young researchers adopt it and turn back to their mentors for advice—what works, what’s hype, and what’s still unknown. The story of CHIR99021 serves as both example and invitation: keep asking hard questions, keep refining the tools, and stay grounded in solid science as the boundaries of what’s possible keep moving outward.
CHIR99021 shows up in many research labs, often spotted in studies about stem cells and disease modeling. It’s a small molecule, catchy name aside, and stands out because it blocks an enzyme called GSK-3. Scientists lean on this inhibitor to direct the fate of cells, especially when working with human stem cells. The ability to push a cell toward a specific identity fuels advances in everything from regenerative medicine to drug discovery.
GSK-3 acts a bit like a traffic cop for signals inside the cell. By blocking this enzyme, CHIR99021 helps promote self-renewal of stem cells. Researchers can keep stem cells undifferentiated longer and scale up cell production. This keeps workbench experiments going without cells maturing or dying off too soon. Scientists can then guide these stem cells to become neurons, heart muscle, or even insulin-producing pancreatic cells—key for studying diseases like Alzheimer’s or diabetes.
The journey to make useful stem cells for therapy brings plenty of hurdles, including consistency and reproducibility. CHIR99021 gives researchers a lever to pull during the transformation of cells. For example, adding this compound helps turn fibroblasts into neurons with more predictability. In another practical achievement, scientists have coaxed pluripotent stem cells to form mini-organs called organoids. These tiny tissue models let us study diseases or test drugs on living human cells, all without risky or painful biopsies.
It’s easy to overlook a small bottle of powder, but CHIR99021 helps bring ideas closer to the clinic. Drug firms exploring new medicines or gene therapies often start by screening chemical libraries on cells that respond predictably. CHIR99021 allows them to control cell fate and test treatments on the type of human cell most likely to respond. This can shrink the gap between “it worked in mice” and “it might help people.” There are now groups growing liver, gut, or even brain organoids to test treatments for everything from cystic fibrosis to viral infections, with CHIR99021 playing a part.
Relying on one tool has limits. Overuse or misunderstanding of GSK-3 blockers can lead to abnormal cell growth and hide downstream problems, especially in long-term cultures. It’s tempting to see CHIR99021 as a cure-all, but every chemical approach needs clear eyes. The future points to cleaner, more selective compounds and better testing standards. Funding, shared data, and tight lab protocols can help bring more safety and transparency in stem cell work.
Sharing data on results (both hits and misses), studying the long-term effects on cells, and following best practices all help build confidence in research. Open conversations between academic scientists and industry teams give more insight. Bringing together bioethicists, patients, and the wider community helps shape the responsible use of powerful lab tools like CHIR99021. The more people ask tough questions and share what works, the greater the benefit for all.
Lab work runs on details that sometimes feel minor until experiments float off course. CHIR99021 stands out as one of those small yet critical details. As a GSK-3 inhibitor, this molecule plays a big role in stem cell routines, especially in directing what cells grow up to become. Researchers rely on it to keep stem cells from wandering down unwanted paths or to nudge them towards specific fates.
Years spent in academic labs taught me that every cell line can react differently. What worked last semester may look very different now. The literature does a good job flagging 3 µM as a default starting point for human pluripotent stem cell maintenance. Sometimes, even 1 µM holds cells steady, while for boosting Wnt signaling, teams often climb up to 10 µM or a little higher. It’s never one-size-fits-all, but jumping in at 3 µM covers the bases for most needs.
CHIR99021 is far from a magic bullet. Go too low and pathways limp along; cells look dull. Go too high and you risk pushing them toward weird, even toxic, shapes. In my hands, I'd freeze stocks at 10 mM in DMSO. Before each passaging, I'd pull a fresh aliquot. After a week, both stock and media needed tossing. Small changes in routine made a world of difference. Sloppy measure-up led to inconsistent colonies.
It’s tempting to rely on published protocols, but cell culture punishes shortcuts. Studies draw links between GSK-3 inhibitors and cell survival, as well as metabolic changes that linger long after drug removal. Out-of-range doses don’t just waste reagents; they derail entire sets of outcomes. Too much CHIR99021 activates off-target effects. Researchers have documented changes in cellular metabolism and fate even after brief exposure to high levels.
A 2017 review in Stem Cell Reports showed that most protocols for hiPSC or hESC lines recommend between 3 µM and 10 µM for cellular maintenance and differentiation. Several teams pointed out that jumping past 15 µM caused sharp drops in cell viability and created quirky gene expression profiles across cell batches. Reports from the Allen Institute and others stress that tuning dose carefully brings the most reliable results, and that blind faith in published numbers leaves too much to chance.
Quality control matters. Running dose-response curves can sound tedious, yet it’s one of the few things that beats wall-clock consistency. With an LC-MS or plate-reader assay, even early grad students can compare how different concentrations shape outcomes. Peer labs have started sharing protocol tweaks on open science forums, providing dose and duration tips for dozens of common cell lines. As a group, we build reproducibility by being upfront about variations—nobody’s cell cultures look exactly the same.
Anyone ordering CHIR99021 should check the actual batch ID and supplier’s certificate. Minor changes in purity between lots easily slip by, and a five-minute check saves weeks of troubleshooting. Making records public lets everyone spot patterns—like which providers or even storage temperatures tie to surprise results.
Landing on an effective CHIR99021 concentration means combining published starting points with what you see under the microscope. Documentation, routine curve checks, and community honesty go farther than any reagent catalogue. Before setting a new protocol, spend time checking what goes on at a cell level—cells never lie, even when papers do.
Lab life rarely runs on autopilot. Reagents like CHIR99021, a known GSK-3 inhibitor found in many stem cell protocols, require real attention. People sometimes underestimate how much simple storage practices protect experiments from going sideways. In the early days of my own work with small molecules, rushed setups and overlooked labels caused lots of frustration. With a compound like CHIR99021, skipping on proper storage can mean the difference between clean results and a wasted batch of cells.
Anyone ordering CHIR99021 usually receives it as a solid powder. Companies recommend keeping the unopened vial at minus twenty degrees Celsius. A household freezer doesn’t always cut it, but almost every lab now stocks a dedicated -20°C freezer. Moisture in the air runs like a thief, so leave the vial sealed and bring it to room temperature before opening. That simple habit holds off condensation and protects the powder’s integrity.
I’ve learned the hard way that temperature cycles erode quality. Some researchers set aside a working aliquot of CHIR99021, especially once the compound moves to solution. DMSO solutions deserve their own warnings. At room temperature, or even around fridge temps (2-8°C), solutions might survive a week or two. Still, breakdown creeps in if that solution keeps getting pulled in and out for daily use. Wrapping tubes in foil and shading them matters, too, since strong light can destabilize many sensitive molecules.
CHIR99021’s reliability matters to stem cell studies, reprogramming experiments, neurobiology, and many other fields. A compound's activity hangs on stability. Degradation or water uptake can change effective doses or produce by-products, messing with experimental reproducibility. Poor storage is quiet but sneaky—cells behave differently, protocols lose their sharpness, and months of work risk getting tossed out. That lesson sticks fast when it hits a precious project.
Solid CHIR99021 usually holds out for years in a frost-free, dark, dry environment. DMSO stocks spoil more easily, especially as researchers dip into the tube and increase exposure to the air. Anyone who’s spent hours troubleshooting a protocol knows how much time those mistakes cost. To stay organized, many labs record each freeze-thaw, write dates on every aliquot, and stick to a one-month use window for DMSO stocks.
Handling CHIR99021 involves basic, but easy-to-forget, habits. Always let the vial warm to room temperature before opening. Only weigh or pipette under low-humidity conditions, away from direct light. DMSO solutions benefit from single-use aliquots distributed into amber or foil-wrapped tubes. Lab schedules get busy, but skipping these steps ends up burning more time in trouble-shooting errors.
Certain suppliers provide expiry recommendations based on chemical analysis. Trust those over hunches. If a solution goes cloudy, changes color, or just sits for longer than a month, swap it out. Auto-pilot causes most mishaps; keeping a tracking sheet handy reduces errors and builds accountability.
Trusted scientific results start with careful storage. In years of running cell assays, success often hinges on behind-the-scenes attention to small details. CHIR99021 rewards careful handling with rock-steady results. Consistency in storage pays off fastest during stressful projects or grant deadlines—a bit of discipline always beats damage control late in the game.
New lab members sometimes ask why details matter so much. It’s because every small slip adds up. Building these habits into lab culture, along with backup freezers, dated aliquots, and a skeptical eye for old solutions, saves everyone a lot of pain down the line. Simple rules, followed every time, protect both data and morale.
CHIR99021 pops up a lot in cell biology labs, especially for stem cell work and signaling pathway research. Lab groups tend to ask about its solubility because that small step—getting a reagent into solution—makes experiments possible or can derail them from the start. CHIR99021, a GSK-3 inhibitor, comes as a yellow, crystalline powder. The immediate question, once you've received it from a reputable supplier, is how to dissolve it so it behaves as expected.
Anyone who’s tried to dissolve CHIR99021 in water quickly finds cloudy, stubborn mixtures. Its solubility in water is almost nonexistent. That might sound surprising since we often hope any small molecule will blend into water with enough stirring, but this compound doesn’t play ball. The chemistry behind this comes down to its structure—aromatic rings and nitrogen atoms create strong internal bonds that water cannot readily disrupt. So pushing more powder into water only wastes precious stock material.
DMSO stands out as the solvent of choice for CHIR99021. Drop the powder into DMSO, give it a stir, and you see it clear fully—1,000 times more soluble than in water. This isn't unusual; many kinase inhibitors share this behavior. DMSO’s ability to dissolve both polar and non-polar compounds comes from its molecular structure—a polar sulfoxide group paired with space for hydrophobic interactions. Lab protocols recommend reconstituting CHIR99021 at high concentrations in pure DMSO, then diluting it into aqueous media just before use.
Using DMSO as a solvent brings practical issues. Cell-based work often concerns itself with the final DMSO concentration, since anything above half a percent can stress delicate cells. From my own work and reading papers in the stem cell field, researchers nearly always prepare concentrated DMSO stocks, then keep quick calculations on hand to make sure their treatments add minimal DMSO. If you're pipetting a 10 mM stock into media for a 3 µM final dose, you end up with well below that threshold. Still, experienced groups always run a control group—same DMSO concentration, no CHIR99021—so they can tell true drug effects from solvent artifacts.
Every lab conversation about a “failed” experiment circles back to reagent prep sooner or later. Just a pinch of undissolved powder in a stock tube, or an assumption that water will do the job, cuts into consistency between experiments across labs. Missteps here don't just waste reagent; they feed into the wider reproducibility crisis in biomedical science. I’ve sat in lab meetings where everyone is confident that their protocols are airtight, only to learn an undergraduate mixed the stock in PBS, not DMSO, two steps back. Documenting solvent and concentration, checking for full dissolution, and storing stocks in aliquots at -20°C avoids these pitfalls.
It pays to clarify which solvent does the job. Solubility isn't a dry, technical detail—it shapes cell health and the trustworthiness of data. Using DMSO for CHIR99021 isn’t a workaround; it’s the standard for reproducibility and reliable science. Getting these details right saves frustration, protects precious reagents, and lets experimental results tell a true story.
CHIR99021 shows up on the bench in a crisp little vial, looking harmless. Despite its unassuming appearance, it’s a potent small molecule. This compound helps scientists study stem cells, but with its usefulness comes some personal responsibility. Safety matters, and trusting in habits and routines won’t cut it.
Lab coats, gloves, and protective eyewear should be automatic when handling CHIR99021. I’ve watched a gloved hand shield someone from a mess more than once. Nitrile gloves provide a solid barrier. Even short contacts jeopardize skin, so no one should ever abandon gloves for convenience. Eye protection shields you from splashes—one missed step and a pipette tip can surprise you.
Although CHIR99021 doesn’t jump out as volatile, weighing out powders or opening stock solutions can suspend dust or droplets. Working in a certified chemical fume hood acts as a strong protective move. Breathing in even low amounts of chemical powders isn’t good for your future. People in my lab know the exhaust fan’s hum means “I’m thinking ahead.” Keeping your nose clear of harm always pays off in the long run.
Some chemicals wait for light or moisture to cause trouble. CHIR99021 keeps best in a closed vial, tucked into a fridge or freezer, well away from sunlight. I recommend using amber vials—simple but effective. Labeling every container, with both date and identity, keeps confusion and mistakes out of the workspace. Opening an unlabeled vial, finding ambiguous powder, then realizing it could be anything, is an anxiety no one needs.
Spills happen in every lab—no shame in a slip-up. The best response starts before anything spills: everyone should know where spill kits and absorbent pads live. Cleaning a minor CHIR99021 dusting means wetting the area first and wiping with disposable towels. Never sweep or blow to avoid spreading powder. Larger amounts deserve escalation—call safety officers, rope off the area, and use proper chemical cleanup materials. Everyone forgets this approach until they see a scatter of powder turn into a nightmare after someone tries to sweep it dry.
Disposing of CHIR99021 means chemical waste containers—never rinse it down the drain. Each facility sets up its own system, so familiarize yourself with labels and storage locations. Mixing old and new chemicals introduces risk, so separate everything by type. I once saw someone combine incompatible chemicals, leading to a standoff with the safety officer and a lesson in patience and paperwork. Avoid that headache; play by the disposal book.
There’s a world of progress packed into a clear solution of CHIR99021, but a healthy respect for its hazards makes those scientific advances possible. Lean on facts: follow chemical safety databases, timer alarms for fridge storage, and the collective memory of anyone who’s ever made a cleanup mistake. Protocols only protect if you really use them every day. Doing science right means trusting safety steps as much as your hypotheses.
| Names | |
| Preferred IUPAC name | 6-[[2-[(4-Methoxyphenyl)amino]pyrimidin-4-yl]amino]cyclohexane-1-carbonitrile |
| Other names |
CT99021 GSK-3 inhibitor IX GSK3β inhibitor IX |
| Pronunciation | /siː.eɪtʃ.aɪ.ɑr.naɪn.naɪn.oʊ.tuː.wʌn/ |
| Identifiers | |
| CAS Number | 252917-06-9 |
| Beilstein Reference | 3870326 |
| ChEBI | CHEBI:91839 |
| ChEMBL | CHEMBL1077351 |
| ChemSpider | 21715165 |
| DrugBank | DB12051 |
| ECHA InfoCard | 100.214.194 |
| EC Number | SML1046 |
| Gmelin Reference | 877838 |
| KEGG | C11204 |
| MeSH | D06CM021 |
| PubChem CID | 10109344 |
| RTECS number | NJVH4F08W9 |
| UNII | X2M90DB1MY |
| UN number | UN1170 |
| Properties | |
| Chemical formula | C22H18Cl2N8 |
| Molar mass | 465.34 g/mol |
| Appearance | White solid |
| Odor | Odorless |
| Density | 0.98 g/mL |
| Solubility in water | DMSO: ≥32 mg/mL |
| log P | 2.38 |
| Acidity (pKa) | 10.01 |
| Basicity (pKb) | 4.10 |
| Magnetic susceptibility (χ) | -4.6E-6 cm^3/mol |
| Refractive index (nD) | 1.576 |
| Dipole moment | 4.27 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Std molar entropy (S⦵298) of CHIR99021: "635.7 J·mol⁻¹·K⁻¹ |
| Hazards | |
| Main hazards | Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS06, GHS08 |
| Signal word | Warning |
| Hazard statements | H315, H319, H335 |
| Precautionary statements | P264, P270, P273, P280, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 2, Instability: 0, Special: - |
| Flash point | > 230.2°C |
| LD50 (median dose) | > 5000 mg/kg (Rat, oral) |
| NIOSH | Not listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 3-5 μM |
| Related compounds | |
| Related compounds |
CHIR98014 SB216763 BIO LiCl AR-A014418 |
